comparemela.com
Home
Live Updates
Kinaset Therapeutics Appoints Christopher OBrien, MD, PhD, FCCP, as Chief Medical Officer : comparemela.com
Kinaset Therapeutics Appoints Christopher O'Brien, MD, PhD, FCCP, as Chief Medical Officer
Press release content from Business Wire. The AP news staff was not involved in its creation.
Related Keywords
Massachusetts ,
United States ,
Robert Clarke ,
Roger Heerman ,
Chris Obrien ,
Shannon Youngberg ,
Thomas King ,
Inflammation Clinical Development ,
Development Team Leader ,
Head Of Pulmonary Clinical Development ,
Kinaset Therapeutics Inc ,
University Of Connecticut School Medicine ,
College Of Chest Physicians ,
Astrazeneca ,
Atlas Venture ,
Hospital Of The University Pennsylvania ,
Janssen Pharmaceuticals ,
University Of Pennsylvania ,
Critical Care Division ,
Gi Clinical Development ,
Clinical Development At Teva Pharmaceuticals ,
Chriso Brien ,
Chief Medical ,
Chief Executive Officer ,
Life Cycle ,
Symbicort Brand Physician ,
Global Head ,
Late Phase Respiratory ,
Global Medical Science Director ,
Vice President ,
Respiratory Clinical Development ,
Teva Pharmaceuticals ,
Proair Respiclik ,
Pulmonary Clinical Development ,
Compound Development Team ,
Connecticut School ,
Internal Medicine ,
Critical Care Medicine ,
Clinical Instructor ,
Adjunct Clinical Assistant Professor ,
Pulmonary Medicine ,
Kinaset Board ,
Kinaset Therapeutics ,
Chief Business ,
Business Wire ,
Health ,
Business ,
Lung Disease ,
Asthma ,
comparemela.com © 2020. All Rights Reserved.